BMPR2 and pulmonary arterial hypertension: Proteomic screening in ECFC of HPAH patients with BMPRII mutations compared to healthy control subjects revealed translationally controlled tumor protein as a key mediator of endothelial prosurvival and growth signaling in PAH (41).